Bifonazole
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB04794 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 18 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | pulmonary hypertension | KG + DL |
| 2 | kyphoscoliotic heart disease | KG + DL |
| 3 | female breast carcinoma | KG + DL |
| 4 | leprosy | KG + DL |
| 5 | migraine disorder | KG + DL |
| 6 | migraine with brainstem aura | KG + DL |
| 7 | mycotic corneal ulcer | KG + DL |
| 8 | coronary artery disease | KG + DL |
| 9 | anomalous left coronary artery from the pulmonary artery | KG + DL |
| 10 | migraine with or without aura, susceptibility to | KG + DL |
| 11 | oral candidiasis | KG + DL |
| 12 | Prinzmetal angina | KG + DL |
| 13 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 14 | commissural lip fistula | KG + DL |
| 15 | osteoradionecrosis of the mandible | KG + DL |
| 16 | burning mouth syndrome | KG + DL |
| 17 | oral leukoedema | KG + DL |
| 18 | myocardial ischemia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.